Feinuo Beite Huanshijiaonang (非诺贝特缓释胶囊)非诺贝特缓释胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H19990303
生产企业Manufacturer
- 上海爱的发制药有限公司Chinese legal name: 上海爱的发制药有限公司
主要成分Active Ingredients
- 非诺贝特Feinuo Beite
药物知识说明
国药准字H19990303是一种在国家药监局注册认定的药品。该药品含有非诺贝特-6e13365e等成分。
该药品关联的活性成分包括：非诺贝特Feinuo Beite。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：上海爱的发制药有限公司Chinese legal name: 上海爱的发制药有限公司。
您可以探索含有相同成分的其他药品：非诺贝特-6e13365e成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 非诺贝特缓释胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 非诺贝特Feinuo Beite.
Manufacturers recorded for this product: 上海爱的发制药有限公司Chinese legal name: 上海爱的发制药有限公司.
Explore other medicines containing the same ingredient: 非诺贝特 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 非诺贝特缓释胶囊Recorded Chinese name: 非诺贝特缓释胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.25g*10粒0.25 g × 10 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 上海爱的发制药有限公司Chinese legal name: 上海爱的发制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19990303
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19990303
Manufacturer
Chinese legal name: 上海爱的发制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.25 g × 10 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H19990303
生产企业
上海爱的发制药有限公司(国产)
适应症
调血脂药，适用于经适当和正规饮食疗法不能控制的高胆固醇血症和高甘油三脂血症。
用法用量
成人，口服，每次0.2g(一片)，一日1次。
不良反应
1.少数患者服药后有胃肠道不适、嗳气或一过性血清转氨酶及血尿素氮升高;
2.偶有口干、胃纳减退、大便次数增加、腹胀、皮疹、头痛、眩晕及疲乏;
3.罕有肌炎、肌痛和明显的血肌酸磷酸激酶增高。
禁忌
1.严重肾功能不良者。
2.原发性胆汁性肝硬化、长期肝功能不良、原有胆囊病者。
3.对本品过敏者。
注意事项
1.肾功能障碍病人应依据肾脏肌酐清除率减低本品剂量。
2.对诊断的干扰:用本品时血小板计数、血尿素氮、转氨酶、血钙等可能增高;血碱性磷酸酶、γ谷氨酰转肽酶及胆红素可能降低。
3.用药期间定期检查:
(1)全血象及血小板计数。
(2)肝功能试验。
(3)血胆固醇、甘油三酯或低密度与极低密度脂蛋白。
贮藏
阴凉、干燥、密封保存。
规格
0.25g*10粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.